Phase I Clinical Trials
Phase I clinical trials are primarily concerned with assessing a drug's safety. This initial phase of testing is done in a small number of volunteers (20 to 100). The study is designed to determine what happens to the drug in the human body—how it is absorbed, metabolized, and excreted. For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: The eligibility criteria noted below are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any treatment to be undertaken must ultimately be determined on an individual basis by the patient and those involved in the patient's treatment. |
Phase I Clinical Trials
| Study Title | ||||
|---|---|---|---|---|
| Body Location | Study # | Primary Investigator | More Info | |
Lapatinib in Endocrine-Resistant Metastatic Breast Cancer | ||||
| Breast-Female | D0520 | Schwartz | More Info | |
An in vivo Proof of Principle Trial to Determine Whether the Nutritional Supplement Conjugated Linoleic Acid (CLA, Clarinol) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue | ||||
| Breast-Female | D0906 | McGowan | More Info | |
A Phase I Study of Oral Topotecan in Subjects with Cancer and Impaired Renal Function | ||||
| Ill-Defined Sites | F0716 | Lewis | More Info | |
Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma | ||||
| Multiple Myeloma | D0717 | Meehan | More Info | |
An Open-Label, Phase Ib Study to Assess the Long-Term Safety Profile of Pazopanib in Cancer Patients | ||||
| Unknown Sites | F0908 | Lewis | More Info | |
VEG111485: A Phase I, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effect of Repeat Oral Doses of Pazopanib (GW786034) on Cardiac Conduction in Subjects with Solid Tumors | ||||
| F0903 | Lewis | More Info | ||
